Skip to main content Accessibility help
×
×
Home

Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto

  • Isaac M. Marks (a1), Richard P. Swinson (a2), Metin Başoǧlu (a3), Klaus Kuch (a4), Homa Noshirvani (a3), Geraldine O'Sullivan (a3), Paul T. Lelliott (a3), Marlene Kirby (a4), Gary McNamee (a3), Seda Sengun (a3) and Kim Wickwire (a4)...

Abstract

A cross-national randomised trial of alprazolam for chronic panic disorder with agoraphobia was run. Compared with previous trials it had three new features: an exposure therapy contrast group, a six-month treatment-free follow-up, and a low rate of early placebo drop-outs (‘non-evaluables’). The dose of alprazolam was high (5 mg/day). The 154 patients had eight weeks of: alprazolam and exposure (combined treatment); or alprazolam and relaxation (a psychological placebo); or placebo and exposure; or placebo and relaxation (double placebo). Drug taper was from weeks 8 to 16. Follow-up was to week 43. Results were similar at both sites. Treatment integrity was good. All four treatment groups, including double placebo, improved well on panic throughout. On non-panic measures, by the end of treatment, both alprazolam and exposure were effective, but exposure had twice the effect size of alprazolam. During taper and follow-up, gains after alprazolam were lost, while gains after exposure were maintained. Combining alprazolam with exposure marginally enhanced gains during treatment, but impaired improvement thereafter. The new features put previous trials in a fresh light. By the end of treatment, though gains on alprazolam were largely as in previous studies, on phobias and disability they were half those with exposure. Relapse was usual after alprazolam was stopped, whereas gains persisted to six-month follow-up after exposure ceased. Panic improved as much with placebo as with alprazolam or exposure.

Copyright

Corresponding author

Correspondence

References

Hide All
Alkubaisy, T., Marks, I. M., Logsoail, S., et al (1992) The role of exposure homework in phobia reduction: A controlled study. Behavior Therapy, 23, 599621.
Andersch, S., Rosenberg, N. K., Kullinsjö, H., et at (1991) Efficacy and safety of alprazolam, imipramine and placebo in the treatment of panic disorder: a Scandinavian multicenter study. Acta Psychiatrica Scandinavica, (suppl. 365), 1827.
Ballenger, J. C., Burrows, G. D., Dupont, R. L., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial: I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413422.
Başoǧlu, M., Lax, T., Kasvikis, Y., et al (1988) Patterns and predictors of improvement in obsessive compulsive disorder. Journal of Anxiety Disorders, 2, 299317.
Başoǧlu, M., Marks, I. M., Kilic, C., et al (1993a) The relationship between panic, anticipatory anxiety, agoraphobia, and global involvement in panic disorders with agoraphobia treated with alprazolam and exposure. (Submitted for publication.)
Başoǧlu, M., Marks, I. M., Kilic, C., et al (1993b) Alprazolam and exposure for panic disorder with agoraphobia: attribution of improvement to medication predicts subsequent relapse. (Submitted for publication.)
Baxter, L., Schwartz, J. R., Bergman, K. S., et al (1992) PET scan changes after successful drug and behavioral treatment. Archives of General Psychiatry, 49, 681689.
Beck, A. T., Ward, C. H., Mendelson, M., et al (1961) An inventory of measuring depression. Archives of General Psychiatry, 4, 561571.
Bixler, E. O., Kales, A., Manfredi, R. L., et al (1991) Next-day memory impairment with triazolam use. Lancet, 337, 827831.
Bouton, M. E., Kenney, F. A. & Rosengard, C. (1990) State-dependent fear extinction with two benzodiazepine tranquilizers. Behavioral Neuroscience, 104, 4455.
Brown, J. L. & Hague, K. J. (1986) A review of alprazolam withdrawal. Drug Intelligence and Clinical Pharmacology, 20, 837841.
Chouinard, G., Annable, L., Fontaine, R., et al (1982) Alprazolam in the treatment of GAD and panic disorders: a double-blind placebo-controlled study. Psychopharmacology, 77, 229233.
Cross-National Collaborative Panic Study, Second Phase Investigators (CNCPS, SPI) (1992) Drug treatment of panic disorders. Comparative efficacy of alprazolam, imipramine and placebo. British Journal of Psychiatry, 160, 191202.
Derogatis, L. R., Lipman, R. S. & Covi, L. (1973) An out-patient psychiatric rating scale: preliminary report. Psychopharmaco-logical Bulletin, 9, 1328.
Dunner, D. L., Ishiki, D., Avery, D. H., et al (1986) Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. Journal of Clinical Psychiatry, 47, 458460.
Echeburúa, E., Decorral, P. & Bajos, E. G. (1993) Self-exposure and alprazolam in the treatment of agoraphobia without current panic. Behavioural Psychotherapy (in press).
Fiegenbaum, W. (1988) Long-term efficacy of ungraded versus graded massed exposure in agoraphobia. Panic and Phobias 2 (eds Hand, I. & Wittchen, H.-U.), pp. 8388. New York: Springer-Verlag.
Fyer, A. J., Liebowitz, M. R., Gorman, J. M., et al (1987) Discontinuation of alprazolam in panic patients. American Journal of Psychiatry, 144, 303308.
Gelder, M. G. & Marks, I. M. (1966) Severe agoraphobia: a controlled trial. British Journal of Psychiatry, 112, 309319.
Ghosh, A. & Marks, I. M. (1987) Self-treatment of agoraphobia by exposure. Behavior Therapy, 18, 316.
Gray, J. A. (1987) Interactions between drugs and behavior therapy. Theoretical Foundations of Behavior Therapy (eds Eysenck, H. J. & Martin, I.), pp. 433447. New York: Plenum.
Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 5055.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Kellner, C. H. & Uhde, T. W. (1988) CT scanning in panic disorders. Abstract No. 37A. APA Abstracts, Montreal, May 10. Washington, DC: APA.
Klosko, J. S., Barlow, D. H., Tassinari, R. B., et al (1988) Alprazolam vs cognitive behaviour therapy in panic disorder: in Panic and Phobias 2 (eds Hand, I. & Wittchen, H. U.), pp. 5465. New York: Springer-Verlag.
Lader, M. H., Ron, M. & Petursson, H. (1984) Computed axial brain tomography on long-term benzodiazepine users. Psychological Medicine, 14, 203206.
Lavory, P. W., Keller, M. B. & Klerman, G. L. (1984) Relapse in affective disorders: reanalysis of the literature using life table methods. Journal of Psychiatric Research, 18, 1325.
Lelliott, P. T., Marks, I. M., Monteiro, W. O., et al (1987) Agoraphobics 5 years after imipramine and exposure: outcome and predictors. Journal of Nervous and Mental Disease, 175, 599605.
Lesser, I. M., Rubin, R. T., Pecknold, J. C., et al (1988) Secondary depression in panic disorder and agoraphobia. Archives of General Psychiatry, 45, 437443.
Maier, W., Roth, M., Argyle, N., et al (1991) Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder? European Archives of Psychiatry and Clinical Neurosciences, 241, 151158.
Marks, I. M. (1978) Living with Fear. New York: McGraw-Hill.
Marks, I. M. (1985) Psychiatric Nurse Therapists in Primary Care. Research Series. London: Royal College of Nursing.
Marks, I. M. (1986) Behavioural Psychotherapy: Maudsley Pocketbook of Management. Available from Prof. Marks, Institute of Psychiatry, London SE5 8AF.
Marks, I. M. (1987) Fears, Phobias and Rituals. New York: Oxford University Press.
Marks, I. M., Hallam, R. S., Philpott, R., et al (1977) Nursing in Behavioural Psychotherapy. London: Royal College of Nursing.
Marks, I. M. & Mathews, A. M. (1979) Brief standard self-rating for phobic patients. Behavior Research and Therapy, 17, 263267.
Marks, I. M., Gray, S., Cohen, S. D., et al (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework: a controlled trial. Archives of General Psychiatry, 40, 153162.
Marks, I. M., Lelliott, P. T., Başoǧlu, M., et al (1988) Clomipramine and exposure for obsessive-compulsive disorder. British Journal of Psychiatry, 152, 522534.
Marks, I. M., Albuquerque, A., Cottraux, J., et al (1989) The ‘efficacy’ of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Archives of General Psychiatry, 46, 668669.
Marks, I. M., Greist, J., Başoǧlu, M., Noshirvani, H., et al (1992) Comment on the second phase of the Cross-National Panic Study. British Journal of Psychiatry, 160, 202205.
Mavissakalian, M. & Michelson, L. (1986) Agoraphobia: therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry, 47, 117122.
McDonald, R., Marks, I. M. & Blizard, R. (1988) Quality assurance of outcome in mental health care in clinical settings. Health Trends, 20, 111114.
McNamee, G., O'Sullivan, G., Lelliott, P., et al (1989) Telephone-guided treatment for housebound agoraphobics with panic disorder: exposure vs relaxation. Behavior Therapy, 20, 491497.
Mellman, T. A. & Uhde, T. W. (1986) Withdrawal syndrome with gradual tapering of alprazolam. American Journal of Psychiatry, 143, 14641466.
Munjack, D. J., Crocker, B., Cabe, D., et al (1989) Alprazolam, propranolol and placebo in the treatment of panic disorder and agoraphobia with panic attacks. Journal of Clinical Psychopharmacology, 9, 2227.
O'Sullivan, G. & Marks, I. M. (1990) Long-term outcome of phobic and obsessive compulsive disorders after exposure: a review chapter. Handbook of Anxiety, Vol. 4 (eds Noyes, R., Roth, M. & Burrows, G.). Amsterdam: Elsevier.
O'Sullivan, G. & Marks, I. M., Başoǧlu, M., et al (1992) Side effects of alprazolam. (Submitted for publication.)
Pecknold, J. C., Swinson, R. P., Kuch, K., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial: III. Discontinuation effects. Archives of General Psychiatry, 45, 429436.
Schmauss, C. & Krieg, J. C. (1987) Enlargement of CSF spaces in benzodiazepine abusers. Psychological Medicine, 17, 869873.
Sheehan, D. V., Raj, A. B., Harnett-Sheehan, K., et al (1990) Adinazolam sustained release in panic disorder: a pilot study. Irish Journal of Psychological Medicine, 7, 124128.
Spitzer, R. L., Williams, J. B. W. (1983) Structured Clinical Interview for DSM-III, Upjohn version (SCID-UP). Biometric Research Division, New York State Psychiatric Institute.
Tesar, G. E., Rosenbaum, J. F., Pollack, M. H., et al (1987) Clonazepam vs alprazolam in the treatment of panic disorder: interim analysis of a prospective, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 48 (suppl. 10).
Wolpe, J. & Lazarus, A. (1966) Behaviour Therapy Techniques. Oxford: Pergamon.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto

  • Isaac M. Marks (a1), Richard P. Swinson (a2), Metin Başoǧlu (a3), Klaus Kuch (a4), Homa Noshirvani (a3), Geraldine O'Sullivan (a3), Paul T. Lelliott (a3), Marlene Kirby (a4), Gary McNamee (a3), Seda Sengun (a3) and Kim Wickwire (a4)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *